# CoreMedica Laboratories

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/coremedica-laboratories

- Industry: Healthcare
- Headquarters: Lee's Summit, US
- Website: www.coremedicalabs.com
- Latest round: Series A (Aug 25, 2016)
- Investors on record: 1

## About

CoreMedica Laboratories Inc. focuses on delivering innovative medical laboratory services and diagnostic solutions to improve healthcare outcomes. The company aims to enhance patient care through advanced technology and reliable testing procedures.CoreMedica Laboratories Inc. was founded in 2010 in Lee's Summit, US, and operates in the medical diagnostics sector, specializing in laboratory services. In September 2020, Swiss Medical Group SA acquired CoreMedica Europe from CoreMedica Laboratories Inc. The company has participated in three deals, with the most recent occurring on September 24, 2020. CoreMedica has raised a total of USD 2.47 mn through its latest funding round, which also amounts to the total raised to date. The CEO of CoreMedica is Jean-Marc Leroux.CoreMedica Laboratories Inc. provides a range of medical laboratory services including diagnostic testing and analysis. The company utilizes advanced technologies to ensure accurate and timely results, catering to healthcare providers and patients. Their offerings support various medical specialties, aiming to meet the needs of a diverse patient population.CoreMedica's revenue model is primarily based on the provision of laboratory services, where income is generated from diagnostic testing and related services. The company operates on a transactional basis, charging healthcare providers and patients for each service rendered. This structure aligns with common practices in the medical laboratory industry, focusing on direct interactions with clients rather than third-party partnerships.CoreMedica Laboratories Inc. plans to expand its service offerings by launching new diagnostic tests and technologies in the coming quarters. The company targets growth by entering additional markets within North America and exploring potential opportunities in international markets by the end of 2022. The recent funding of USD 2.47 mn will be utilized to support the development of new products and facilitate market entry strategies, ensuring the company can scale operations effectively.

## Funding rounds

- Series A, Aug 25, 2016 — Gore Range Capital

## Investors

- Gore Range Capital (https://capitalatlas.ai/funds/gore-range-capital) — Series A